Humana’s (HUM) “Neutral” Rating Reaffirmed at Cantor Fitzgerald

Humana (NYSE:HUM)‘s stock had its “neutral” rating restated by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $290.00 price objective on the insurance provider’s stock. Cantor Fitzgerald’s target price would indicate a potential upside of 10.87% from the company’s current price.

Several other equities analysts have also issued reports on HUM. Morgan Stanley dropped their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday. Wells Fargo & Company dropped their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. Barclays raised their target price on Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 22nd. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, Piper Sandler increased their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $291.32.

Humana Trading Up 1.6 %

Shares of HUM stock opened at $261.56 on Wednesday. Humana has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $31.49 billion, a price-to-earnings ratio of 23.07, a PEG ratio of 2.11 and a beta of 0.56. The stock has a 50-day moving average of $273.00 and a 200-day moving average of $295.72.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities research analysts forecast that Humana will post 16.11 earnings per share for the current year.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.32% of the company’s stock.

Institutional Trading of Humana

Several institutional investors and hedge funds have recently made changes to their positions in HUM. FNY Investment Advisers LLC grew its position in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after purchasing an additional 26,856 shares in the last quarter. Retirement Systems of Alabama grew its holdings in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. PDT Partners LLC grew its holdings in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after acquiring an additional 2,660 shares in the last quarter. Secure Asset Management LLC purchased a new stake in shares of Humana during the fourth quarter valued at approximately $244,000. Finally, Ontario Teachers Pension Plan Board lifted its holdings in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after acquiring an additional 71,910 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.